Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study

Recruiting Observational Study
Glioblastoma Multiforme, Adult Glioblastoma or Gliosarcoma Glioblastoma, Adult
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
128 (estimated)
Sponsor
Sied Kebir · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The study aims to investigate the prognostic significance of olfactory function in patients with glioblastoma. We are examining olfactory function at various points during therapy and correlating the results with survival data. In addition, neurocognitive tests will be carried out to correlate the results of olfactory function with the patient's cognitive abilities. Investigations into the quality…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * At least 18 years of age * Newly-diagnosed glioblastoma (IDH wild-type) * Never received prior chemotherapy * Never received radiotherapy to the head or neck before * KPS ≥ 70 * No history of severe head or brain trauma requiring ICU admission or classified as Glasgow Coma Sca…
Contacts

Christoph Oster, Dr. med.

+49201-723-82598

christoph.oster@uk-essen.de

CONTACT

Sied Kebir, PD Dr. med.

+49201-723-83133

sied.kebir@uk-essen.de

CONTACT